Drug-induced extrapyramidal syndromes: implications for contemporary practice

SN Caroff, EC Campbell - Psychiatric Clinics, 2016 - psych.theclinics.com
Although the origins of antipsychotic pharmacology began with the search for compounds to
improve anesthesia, clinicians reported unusual “psychic indifference” as the defining effect …

Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study

L Hou, U Heilbronner, F Degenhardt, M Adli… - The Lancet, 2016 - thelancet.com
Background Lithium is a first-line treatment in bipolar disorder, but individual response is
variable. Previous studies have suggested that lithium response is a heritable trait. However …

Pharmacogenetics of tardive dyskinesia: an updated review of the literature

RK Lanning, CC Zai, DJ Müller - Pharmacogenomics, 2016 - Taylor & Francis
Tardive dyskinesia (TD) is a serious and potentially irreversible side effect of long-term
exposure to antipsychotic medication characterized by involuntary trunk, limb and orofacial …

Comparative effectiveness of clozapine and standard antipsychotic treatment in adults with schizophrenia

TS Stroup, T Gerhard, S Crystal… - American Journal of …, 2016 - Am Psychiatric Assoc
Objective: The authors compared the effectiveness of initiating treatment with either
clozapine or a standard antipsychotic among adults with evidence of treatment-resistant …

Altered interleukin-18 levels are associated with cognitive impairment in chronic schizophrenia

JQ Wu, YL Tan, SP Tan, MH Xiu, ZR Wang… - Journal of psychiatric …, 2016 - Elsevier
The pathophysiology of cognitive deficits in schizophrenia may involve the
neuroinflammation mediated by cytokines. This study examined the IL-18 levels, the …

Pharmacogenetic study of antipsychotic induced acute extrapyramidal symptoms in a first episode psychosis cohort: role of dopamine, serotonin and glutamate …

S Mas, P Gassó, A Lafuente, M Bioque… - The …, 2016 - nature.com
This study investigated whether the risk of presenting antipsychotic (AP)-induced
extrapyramidal symptoms (EPS) could be related to single-nucleotide polymorphisms …

Toward a global roadmap for precision medicine in psychiatry: challenges and opportunities

S Dalvie, N Koen, N McGregor, K O'Connell… - OMICS: A Journal of …, 2016 - liebertpub.com
Mental disorders represent a major public health burden worldwide. This is likely to rise in
the next decade, with the highest increases predicted to occur in low-and middle-income …

The identification of novel genetic variants associated with antipsychotic treatment response outcomes in first-episode schizophrenia patients

BI Drögemöller, R Emsley, B Chiliza… - Pharmacogenetics …, 2016 - journals.lww.com
Background Although antipsychotics are integral to the treatment of schizophrenia, drug
efficacy varies between patients. Although it has been shown that antipsychotic treatment …

Pharmacogenetic studies of drug response in schizophrenia

MJ Arranz, C Gallego, J Salazar… - Expert Review of …, 2016 - Taylor & Francis
Treatment with antipsychotics is marred by frequent failure and adverse reactions. About a
third of treated patients will not improve adequately, and more than 60% will develop severe …

Pharmacogenetics of the efficacy of antipsychotic drugs in schizophrenia

MJ Arranz, JP Blanco, BA Samperiz - … on Response to Drug Treatment for …, 2016 - Springer
Response to pharmacotherapy is highly variable, complex and difficult to predict. Genetic
factors influence, at least partially, clinical response to drugs. It has been proposed that the …